Bone Morphogenetic Protein-9 Controls Pulmonary Vascular Growth and Remodeling

Nihel Berrebeh, Yvon Mbouamboua, Raphaël Thuillet, Mina Ottaviani, Mustapha Kamel Chelgham, Virginie Magnone, Agnès Desroches-Castan, Nicolas Ricard, Ignacio Anegon, Séverine Remy, Ralph Theo Schermuly, Kevin Lebrigand, Baktybek Kojonazarov, Laurent Savale, Marc Humbert, Sabine Bailly, Pascal Barbry, Ly Tu, Christophe Guignabert
doi: https://doi.org/10.1101/2023.06.02.23290910

Article Information

doi 
https://doi.org/10.1101/2023.06.02.23290910
History 
  • June 5, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Nihel Berrebeh, (PharmD, PhD)1,2,
  2. Yvon Mbouamboua, (PhD)3,
  3. Raphaël Thuillet, (BSc)1,2,
  4. Mina Ottaviani, (BSc)1,2,
  5. Mustapha Kamel Chelgham, (MSc)1,2,
  6. Virginie Magnone, (PhD)3,
  7. Agnès Desroches-Castan, (PhD)4,
  8. Nicolas Ricard, (PhD)4,
  9. Ignacio Anegon, (MD)5,
  10. Séverine Remy, (PhD)5,
  11. Ralph Theo Schermuly, (PhD)6,
  12. Kevin Lebrigand, (PhD)3,
  13. Baktybek Kojonazarov, (PhD)6,
  14. Laurent Savale, (MD, PhD)1,2,7,
  15. Marc Humbert, (MD, PhD)1,2,7,
  16. Sabine Bailly, (PhD)4,
  17. Pascal Barbry, (PhD)3,
  18. Ly Tu, (PhD)1,2,# and
  19. Christophe Guignabert, (PhD)1,2,#,*
  1. 1INSERM UMR_S 999 « Pulmonary Hypertension: Pathophysiology and Novel Therapies », Hôpital Marie Lannelongue, 92350 Le Plessis-Robinson, France
  2. 2Université Paris-Saclay, Faculté de Médecine, Pulmonary Hypertension: Pathophysiology and Novel Therapies, 94276 Le Kremlin-Bicêtre, France
  3. 3Université Côte d’Azur and CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, F06560 Sophia Antipolis, France
  4. 4Biosanté unit U1292, Grenoble Alpes University, INSERM, CEA, F-38000 Grenoble, France
  5. 5Center for Research in Transplanation and Translational Immunology, Plateforme Trangénèse Rat & Immuno Phénomique, INSERM 1064 & SFR François Bonamy, CNRS UMS3556, F44098 Nantes, France
  6. 6Department of Internal Medicine, Member of the German Center of Lung Research (DZL), Justus-Liebig-University of Giessen (JLU), Aulweg 130, Giessen, 35392, Germany
  7. 7Assistance Publique - Hôpitaux de Paris (AP-HP), Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre, 94270 Le Kremlin-Bicêtre, France
  1. ↵*Corresponding author: Christophe Guignabert, Ph.D (ORCID ID: 0000-0002-8545-4452) Université Paris Saclay – INSERM, UMR_S 999: “Pulmonary Hypertension: Pathophysiology and Novel Therapies” Faculté de Médecine Paris-Saclay - Bâtiment de recherche (2e étage), 63 Rue Gabriel Péri, 94276 Le Kremlin Bicêtre, FRANCE, Tel: +33 1 40948833 - E-mail: christophe.guignabert{at}inserm.fr

  1. ↵# These authors contributed equally to this work

Back to top
Posted June 05, 2023.
Download PDF
Data/Code
Email
Bone Morphogenetic Protein-9 Controls Pulmonary Vascular Growth and Remodeling
Nihel Berrebeh, Yvon Mbouamboua, Raphaël Thuillet, Mina Ottaviani, Mustapha Kamel Chelgham, Virginie Magnone, Agnès Desroches-Castan, Nicolas Ricard, Ignacio Anegon, Séverine Remy, Ralph Theo Schermuly, Kevin Lebrigand, Baktybek Kojonazarov, Laurent Savale, Marc Humbert, Sabine Bailly, Pascal Barbry, Ly Tu, Christophe Guignabert
medRxiv 2023.06.02.23290910; doi: https://doi.org/10.1101/2023.06.02.23290910
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area